2020 annual financial data
Immuneering Corporation - Class A Common Stock 2020 Operating margin
Immuneering Corporation - Class A Common Stock 2020 operating margin with verif…
Direct answer
Operating margin was -739.01%.
Operating income was -17,082,554 USD and net income was -17,039,898 USD.
Operating cash flow was -14,620,825 USD.
Get free Immuneering Corporation - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,311,535 USD
- Operating income
- -17,082,554 USD
- Net income
- -17,039,898 USD
- Operating cash flow
- -14,620,825 USD
Explore related company data
View all 2020 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Immuneering Corporation - Class A Common Stock financial years